These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 24920728)
1. Toll-like receptors and hypertension. Singh MV; Abboud FM Am J Physiol Regul Integr Comp Physiol; 2014 Sep; 307(5):R501-4. PubMed ID: 24920728 [TBL] [Abstract][Full Text] [Related]
2. Signaling to NF-kappaB by Toll-like receptors. Kawai T; Akira S Trends Mol Med; 2007 Nov; 13(11):460-9. PubMed ID: 18029230 [TBL] [Abstract][Full Text] [Related]
3. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Fitzgerald KA; Palsson-McDermott EM; Bowie AG; Jefferies CA; Mansell AS; Brady G; Brint E; Dunne A; Gray P; Harte MT; McMurray D; Smith DE; Sims JE; Bird TA; O'Neill LA Nature; 2001 Sep; 413(6851):78-83. PubMed ID: 11544529 [TBL] [Abstract][Full Text] [Related]
4. Angiotensin II-induced hypertension and cardiac hypertrophy are differentially mediated by TLR3- and TLR4-dependent pathways. Singh MV; Cicha MZ; Nunez S; Meyerholz DK; Chapleau MW; Abboud FM Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1027-H1038. PubMed ID: 30793936 [TBL] [Abstract][Full Text] [Related]
5. Toll-like receptors: from the discovery of NFkappaB to new insights into transcriptional regulations in innate immunity. Doyle SL; O'Neill LA Biochem Pharmacol; 2006 Oct; 72(9):1102-13. PubMed ID: 16930560 [TBL] [Abstract][Full Text] [Related]
6. NF-κB activation via MyD88-dependent Toll-like receptor signaling is inhibited by trichothecene mycotoxin deoxynivalenol. Sugiyama K; Muroi M; Kinoshita M; Hamada O; Minai Y; Sugita-Konishi Y; Kamata Y; Tanamoto K J Toxicol Sci; 2016 Apr; 41(2):273-9. PubMed ID: 26961612 [TBL] [Abstract][Full Text] [Related]
7. To con protection: TIR-domain containing proteins (Tcp) and innate immune evasion. Patterson NJ; Werling D Vet Immunol Immunopathol; 2013 Sep; 155(3):147-54. PubMed ID: 23871438 [TBL] [Abstract][Full Text] [Related]
17. Suppression of MyD88- and TRIF-dependent signaling pathways of Toll-like receptor by (-)-epigallocatechin-3-gallate, a polyphenol component of green tea. Youn HS; Lee JY; Saitoh SI; Miyake K; Kang KW; Choi YJ; Hwang DH Biochem Pharmacol; 2006 Sep; 72(7):850-9. PubMed ID: 16890209 [TBL] [Abstract][Full Text] [Related]
18. Induction of in vitro reprogramming by Toll-like receptor (TLR)2 and TLR4 agonists in murine macrophages: effects of TLR "homotolerance" versus "heterotolerance" on NF-kappa B signaling pathway components. Dobrovolskaia MA; Medvedev AE; Thomas KE; Cuesta N; Toshchakov V; Ren T; Cody MJ; Michalek SM; Rice NR; Vogel SN J Immunol; 2003 Jan; 170(1):508-19. PubMed ID: 12496438 [TBL] [Abstract][Full Text] [Related]
19. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors. Horng T; Barton GM; Flavell RA; Medzhitov R Nature; 2002 Nov; 420(6913):329-33. PubMed ID: 12447442 [TBL] [Abstract][Full Text] [Related]
20. Innate immunity and adipocyte function: ligand-specific activation of multiple Toll-like receptors modulates cytokine, adipokine, and chemokine secretion in adipocytes. Kopp A; Buechler C; Neumeier M; Weigert J; Aslanidis C; Schölmerich J; Schäffler A Obesity (Silver Spring); 2009 Apr; 17(4):648-56. PubMed ID: 19148127 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]